Petros Pharmaceuticals PTPI Estimates

OTC PTPI
$0.00 +0.00 (+0.00%)
At close: Oct 15, 2026 · 4:00 PM EDT
Analyst Estimates

Petros Pharmaceuticals, Inc. Revenue Estimates

Periods 26
Next Period Q3 24
Consensus 1.37 M

Analysts expect Petros Pharmaceuticals, Inc. to report revenue of 1.37 M for Q3 24, against a range of 1.31 M to 1.43 M. The most recent reported quarter, Q2 24, came in at 1.42 M, a 7.1% beat against the 1.33 M consensus.

Metric Q2 23Q3 23Q1 24Q2 24Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27Q3 27Q4 27Q1 28Q2 28Q3 28Q4 28Q1 29Q2 29Q3 29Q4 29
Reported (Actual) 1.96 M1.68 M1.39 M1.42 M--------
High Estimate --1.46 M1.45 M1.43 M1.45 M1.47 M1.43 M1.42 M1.41 M3.19 M2.81 M
Low Estimate --1.21 M1.20 M1.31 M1.26 M1.26 M1.29 M1.24 M1.32 M2.86 M2.43 M
Consensus Estimate --1.33 M1.33 M1.37 M1.36 M1.36 M1.36 M1.33 M1.37 M3.02 M2.62 M
Analyst Estimates

Petros Pharmaceuticals, Inc. Earnings Per Share (EPS) Estimates

Periods 26
Next Period Q2 24
Consensus -9.47

Analysts expect Petros Pharmaceuticals, Inc. to report earnings per share of -9.47 for Q2 24, against a range of -10.29 to -8.65. The most recent reported quarter, Q2 26, came in at -0.02, a 101.4% miss against the 1.48 consensus.

Metric Q2 23Q3 23Q1 24Q2 24Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27Q3 27Q4 27Q1 28Q2 28Q3 28Q4 28Q1 29Q2 29Q3 29Q4 29
Reported (Actual) -30.50-53.75-42.25----0.20--0.01--0.02--
High Estimate ---42.32-8.65-6.99-8.30-34.161.425.741.18-33.731.567.261.34
Low Estimate ---47.36-10.29-8.21-9.26-39.541.284.720.96-36.651.406.761.22
Consensus Estimate ---44.84-9.47-7.60-8.78-36.851.355.231.07-35.191.487.011.28

Petros Pharmaceuticals, Inc. Estimates API

Pull Wall Street consensus for Petros Pharmaceuticals, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/estimates?ticker=PTPI&mode=revenue&api_key=YOUR_API_KEY